Shanghai Int Medical Instruments Co. Ltd. has announced an update on its proposed acquisition of a controlling stake in a Target Company, which specializes in aortic and peripheral vascular interventional medical devices. The acquisition, which involves the Hong Kong Company and Cayman Company as part of the ownership structure, is set to enhance Shanghai Int Medical Instruments' capabilities in medical device innovation and sales. The State Administration for Market Regulation has issued a decision approving the anti-monopoly examination related to the acquisition. Additionally, the Target Company has completed financial verifications of its registered capital, confirmed by the Purchasers. This strategic move is expected to consolidate the financial results of the Target Company with those of Shanghai Int Medical Instruments, aiming to strengthen its market presence and expand its product offerings.